-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Upgrades NeoGenomics to Buy, Announces $11 Price Target

Benzinga·04/29/2026 19:13:48
Listen to the news
Benchmark analyst Bruce Jackson upgrades NeoGenomics (NASDAQ:NEO) from Hold to Buy and announces $11 price target.